CR

Crane Company

63
Fundamentals65/ 100
Valuation42/ 100
Upside potential65/ 100
Risk potential15/ 100

CR has the edge over RKLB overall, supported by lower modeled downside.

RKLB

Rocket Lab USA, Inc.

56
Fundamentals66/ 100
Valuation50/ 100
Upside potential66/ 100
Risk potential46/ 100

RKLB offers stronger valuation, but that advantage does not outweigh its weaker overall profile.

CR Fundamentals

MetricStatus
Strong
Healthy
Healthy
Healthy

CR's revenue, profitability, cash flow and balance sheet are all currently healthy.

RKLB Fundamentals

MetricStatus
Strong
Under pressure
Weak
Unavailable

RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.

CR PE Valuation

CHEAPFAIREXPENSIVE11x21x32x42x
CHEAPFAIREXPENSIVE11x21x32x42x
LevelPEPriceVs current
Forward27x$209—
Cheap29x$167-20%
Fair31x$180-14%
Expensive34x$198-5.7%
Current36x$209—

Historical ranges are pointers, not guarantees.

CR's PE is in its expensive range at 36x. If earnings grow as analysts expect, today's price would be 27x next year's earnings, in its cheap range.

RKLB PE Valuation

RKLB has no meaningful PE right now: it lost money over the past year.

CR Forward outlook

MetricOutlook
Strongly improving
Strong growth
Growth
Improving
Limited
High

Analysts expect earnings and revenue growth for CR, with profitability improving.

RKLB Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Limited
Low

Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

CR Risk to reward

ScenarioChangePrice
Upside+29%$270.41
Downside-15%$177.21

Calculated from the latest close: $209.48 on Nov 12.

CR trails RKLB on modeled risk to reward, with less potential upside relative to its potential downside.

RKLB Risk to reward

ScenarioChangePrice
Upside+88%$120.71
Downside-46%$34.64

Calculated from the latest close: $64.07 on Nov 12.

RKLB has a better modeled risk to reward balance than CR, with more potential upside relative to its potential downside.

CR Earnings Per Share

Q4 2023: $4.45Q1 2024: $4.48Q2 2024: $4.92Q3 2024: $5.29Q4 2024: $5.06Q1 2025: $5.77Q2 2025: $6.01Q3 2025: $6.24Q4 2025: $6.26Q1 2026: $5.57Q2 2026: $5.73Q3 2026: $5.83Forward: $7.81
Q4 2023: $4.45Q1 2024: $4.48Q2 2024: $4.92Q3 2024: $5.29Q4 2024: $5.06Q1 2025: $5.77Q2 2025: $6.01Q3 2025: $6.24Q4 2025: $6.26Q1 2026: $5.57Q2 2026: $5.73Q3 2026: $5.83Forward: $7.81
QuarterTTM EPSYoY
Forward$7.81+34%
Q3 2026$5.83-6.6%
Q2 2026$5.73-4.7%
Q1 2026$5.57-3.5%
Q4 2025$6.26+24%
Q3 2025$6.24+18%
Q2 2025$6.01+22%
Q1 2025$5.77+29%
Q4 2024$5.06+14%

CR has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.

RKLB Earnings Per Share

Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
QuarterTTM EPSYoY
Q3 2026-$0.36+$0.03
Q2 2026-$0.27+$0.19
Q1 2026-$0.32+$0.09
Q4 2025-$0.37+$0.01
Q3 2025-$0.39-$0.02
Q2 2025-$0.46-$0.11
Q1 2025-$0.41-$0.04
Q4 2024-$0.38$0.00

RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.

CR Quarterly Revenue

Q4 2023: $533MQ1 2024: $565MQ2 2024: $581MQ3 2024: $597MQ4 2024: $544MQ1 2025: $558MQ2 2025: $577MQ3 2025: $589MQ4 2025: $581MQ1 2026: $696MQ2 2026: $725MQ3 2026: $755M
Q4 2023: $533MQ1 2024: $565MQ2 2024: $581MQ3 2024: $597MQ4 2024: $544MQ1 2025: $558MQ2 2025: $577MQ3 2025: $589MQ4 2025: $581MQ1 2026: $696MQ2 2026: $725MQ3 2026: $755M
QuarterRevenueYoY
Q3 2026$754.6M+28%
Q2 2026$724.7M+26%
Q1 2026$696.4M+25%
Q4 2025$581M+6.8%
Q3 2025$589.2M-1.3%
Q2 2025$577.2M-0.7%
Q1 2025$557.6M-1.4%
Q4 2024$544.1M+2.1%

CR's revenue is recovering but still below its 2021 peak: $755M last quarter, up 28% from the same quarter a year ago.

RKLB Quarterly Revenue

Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
QuarterRevenueYoY
Q3 2026$267.8M+73%
Q2 2026$234.1M+62%
Q1 2026$200.3M+63%
Q4 2025$179.7M+36%
Q3 2025$155.1M+48%
Q2 2025$144.5M+36%
Q1 2025$122.6M+32%
Q4 2024$132.4M+121%

RKLB has the edge over CR on sales, with more consistent year-over-year improvement.

CR Free Cash Flow

Q4 2023: $147MQ1 2024: −$89MQ2 2024: $55MQ3 2024: $73MQ4 2024: $183MQ1 2025: −$60MQ2 2025: $89MQ3 2025: $117MQ4 2025: $196MQ1 2026: −$40MQ2 2026: $108MQ3 2026: $116M
Q4 2023: $147MQ1 2024: −$89MQ2 2024: $55MQ3 2024: $73MQ4 2024: $183MQ1 2025: −$60MQ2 2025: $89MQ3 2025: $117MQ4 2025: $196MQ1 2026: −$40MQ2 2026: $108MQ3 2026: $116M
QuarterFree cash flowYoY
Q3 2026$116.3M-0.4%
Q2 2026$107.7M+21%
Q1 2026-$40.2M+$20.2M
Q4 2025$196M+7.2%
Q3 2025$116.8M+61%
Q2 2025$88.9M+63%
Q1 2025-$60.4M+$28.6M
Q4 2024$182.9M+25%

CR has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.

RKLB Free Cash Flow

Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
QuarterFree cash flowYoY
Q3 2026-$23.9M+$45.5M
Q2 2026-$110.1M-$54.8M
Q1 2026-$77.4M+$5.5M
Q4 2025-$114.2M-$90.2M
Q3 2025-$69.4M-$27.5M
Q2 2025-$55.3M-$26.9M
Q1 2025-$82.9M-$61.1M
Q4 2024-$23.9M+$28.7M

RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.

CR Total Shares

Q4 2023: 58MQ1 2024: 58MQ2 2024: 58MQ3 2024: 58MQ4 2024: 58MQ1 2025: 59MQ2 2025: 59MQ3 2025: 59MQ4 2025: 59MQ1 2026: 59MQ2 2026: 59MQ3 2026: 59M
Q4 2023: 58MQ1 2024: 58MQ2 2024: 58MQ3 2024: 58MQ4 2024: 58MQ1 2025: 59MQ2 2025: 59MQ3 2025: 59MQ4 2025: 59MQ1 2026: 59MQ2 2026: 59MQ3 2026: 59M
PeriodChange %Net change
Quarterly+0.2%+100K shares
1 year+0.3%+200K shares
3 years+2.3%+1.3M shares
5 years-1.2%-700K shares
Available history-1.2%-700K shares

CR has the edge over RKLB on shareholder dilution, with a more favorable share count trend.

RKLB Total Shares

Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
PeriodChange %Net change
Quarterly+3.6%+22.6M shares
1 year+23%+124M shares
3 years+35%+168M shares
5 years+46%+204M shares

RKLB has 652M diluted shares, up 23% from a year ago.

CR Net Leverage

Q4 2023: -0.2xQ1 2024: 0.4xQ2 2024: 0.4xQ3 2024: 0.2xQ4 2024: -0.1xQ1 2025: -0.4xQ2 2025: -0.6xQ3 2025: -0.9xQ4 2025: 1.4xQ1 2026: 1.7xQ2 2026: 1.4xQ3 2026: 1.1x
Q4 2023: -0.2xQ1 2024: 0.4xQ2 2024: 0.4xQ3 2024: 0.2xQ4 2024: -0.1xQ1 2025: -0.4xQ2 2025: -0.6xQ3 2025: -0.9xQ4 2025: 1.4xQ1 2026: 1.7xQ2 2026: 1.4xQ3 2026: 1.1x
QuarterNet LeverageStatus
Q3 20261.1xHealthy
Q2 20261.4xHealthy
Q1 20261.7xHealthy
Q4 20251.4xHealthy
Q3 2025-0.9xNet Cash
Q2 2025-0.6xNet Cash
Q1 2025-0.4xNet Cash
Q4 2024-0.1xNet Cash

CR's net debt is about 1.1 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.

RKLB Net Leverage

RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

CR Weekly Momentum

MetricValueStatus
RSI54.1Neutral
Stochastic47.0Neutral

CR's weekly RSI is 54 (neutral) and its Stochastic is 47 (neutral).

RKLB Weekly Momentum

MetricValueStatus
RSI46.8Neutral
Stochastic27.6Neutral

RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).

CR PE vs Industrials Sector

MetricCRSector medianRelative
PE36x24x49% above
PE %916031 pts above

CR is trading at 36x earnings, a 49% premium to the Industrials sector's median of 24x.

RKLB PE vs Industrials Sector

RKLB has no meaningful PE right now: it lost money over the past year.

CR Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$202.13.6% above
20 week MA$208.40.5% above
50 week MA$197.06.3% above
100 week MA$184.913% above

CR has stronger trend alignment. CR is above 4 of 4 weekly averages versus RKLB above 3 of 5.

RKLB Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$61.44.3% above
20 week MA$68.15.9% below
50 week MA$77.617% below
100 week MA$56.513% above
200 week MA$31.4104% above

RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.

CR Yearly ROI

YearStart priceEnd priceROI
2023$105.7$118.1+12%
2024$118.1$153.9+30%
2025$153.9$187.8+22%
2026 YTD$187.8$209.5+12%

CR has the edge over RKLB on returns for 2026, with the stronger performance.

RKLB Yearly ROI

YearStart priceEnd priceROI
2020$9.82$10.3+4.9%
2021$10.3$12.0+17%
2022$12.0$3.77-69%
2023$3.77$5.53+47%
2024$5.53$27.2+392%
2025$27.2$70.7+160%
2026 YTD$70.7$64.1-9.3%

RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.

Give your agent the market.

Get API key